Diabetic Nephropathy Market to Hit US$ 3,145.9 Million by 2020, Lucrative Opportunities Exist for Combination Therapies - by MRRSE.
Browse Full Report with TOC : http://www.mrrse.com/diabetic-nephropathy-market
Diabetic nephropathy, a condition that increases the risk of mortality in diabetes patients, is being widely reported across the world due to the sheer increase in the number of obese people and diabetics. The disease affects the kidneys, ultimately rendering them ineffective. This has necessitated investments in formulating treatments for diabetic nephropathy, leading to a teeming therapy pipeline in major markets of the world.
The drugs, however, are faced with long approval times (essentially because there are scores of regulatory hurdles) making it difficult for pharma companies to bring novel products to the market in short turnaround times. Moreover, there is a general lack of broader therapeutic management for the disease. All of these factors will play a role in curtailing the growth of the global diabetic nephropathy market.
They can provide sample pages for the better understanding of this report. To request a sample of this Report, kindly visit at http://www.mrrse.com/enquiry/119
The report notes that North America has the highest degree of awareness about diabetic nephropathy. Government initiatives such as the National Kidney Disease Education Program can be credited for this. The market here continues to organically grow because of a parallel increase in the number of people suffering from diabetes in America. Estimates from the SciELO Public Health state that in 2000 about 35 million people in North America suffered from diabetes mellitus; by 2025, this number will soar to 64 million in the region. The European diabetic nephropathy market is also on an upswing because here too, diabetes is increasingly being reported. International Diabetes Federation (IDF) says that the amount expended on diabetes treatment in the European region was pegged at US$105.5 billion in 2010, and will hit US$124.6 billion by 2030.
The highest potential for growth lies in the Asia Pacific diabetic nephropathy market. The region is witnessing an escalation in the incidence of diabetic nephropathy in Japan and other Southeast Asian nations.
Moving forward, companies in the diabetic nephropathy market have a lucrative opportunity in developing combination therapies.
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. Headquartered in New York, U.S., MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE's repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90 State Street,
Albany NY - 12207
Contact via Email
90, State Street
Albany, NY - 12207
Email : email@example.com
Read the full story here: http://www.pr.com/press-release/623270
|Printer friendly Cite/link Email Feedback|
|Publication:||PR.com (Press Releases)|
|Date:||Jun 10, 2015|
|Previous Article:||PECB International Signs a Partnership Agreement with Novation Conseils.|
|Next Article:||EmpoweringCPO Expands Its Portfolio of Services to Now Include Low Cost Country Sourcing.|